Management of corneal perforation should include the administration of topical antibiotics to prevent secondary infections, the employment of medications that promote corneal re-epithelialization, corneal tarsorrhaphy, and the suspension of VEGFR-TKI treatment until healing occurs. This evidence concerns the gene KDR and infection.